InfuSystemsvsJohnson & Johnson

INFU and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

INFU

InfuSystems Holdings, Inc.

$14.17

Value $286M

-3.41%
INFU's page

InfuSystems (INFU) has a market value of $286M and Johnson & Johnson (JNJ) $641B. Over the last year, with dividends, INFU moved +52.2% and JNJ +36.1%. The P/E is 30.3 for INFU and 39.9 for JNJ. Dividend yield: INFU none, JNJ 1.98%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    INFU$286M

    JNJ$641B

    JNJ is 2,239 times INFU

  • Revenue, 12 months

    INFU$144M

    JNJ$99.3B

    JNJ is 688 times INFU

  • Net income, 12 months

    INFU$9.4M

    JNJ$16.1B

    JNJ is 1,705 times INFU

  • Operating margin

    INFU9.8%

    JNJ–

  • ROIC

    INFU12.7%

    JNJ12.4%

    0.3 points apart

  • P/E

    INFU30.3

    JNJ39.9

    JNJ is 1.3 times INFU

  • Dividend yield

    INFU0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    INFU-23.3%

    JNJ+88.4%

    111.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

INFU-23.3%

JNJ+88.4%

5010015020020222023202420252026
Returns by period
PeriodINFUWith dividendsJNJWith dividends
1 year since November 18, 2025+52.2%Price +52.2%+36.1%Price +33.1%
3 years since November 17, 2023+52.5%+15.1% a yearPrice +52.5%+93.5%+24.6% a yearPrice +77.7%
5 years since November 18, 2021-23.3%-5.2% a yearPrice -23.3%+88.4%+13.5% a yearPrice +63.9%
10 years since November 21, 2016+626.7%+21.9% a yearPrice +626.7%+201.6%+11.7% a yearPrice +131.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

INFUInfuSystemsJNJJohnson & Johnson

Valuation

INFUJNJ
Valuation
Price$14.17$266.16
Market value$286M$641B
Enterprise value (EV)$297M$669B
P/E30.339.9
P/E, 5-year median–21.9
P/B4.57.9
EV/EBIT20.937.7
Free cash flow yield8.6%3.2%

Results and growth

INFUJNJ
Results and growth
Revenue, 12 months$144M$99.3B
Net income, 12 months$9.4M$16.1B
Free cash flow, 12 months$25M$20.6B
Earnings per share, 12 months$0.44$6.59
Revenue growth, year on year6.4%6.1%
Revenue growth a year, past+8.1%over 5 years+2.7%over 5 years
EPS growth a year, past-17.3%over 5 years+14.9%over 5 years

Margins and returns on capital

INFUJNJ
Margins and returns on capital
Gross margin57.6%67.6%
Operating margin9.8%–
Net margin6.5%16.2%
ROIC12.7%12.4%
ROE16.0%19.7%

Balance sheet

INFUJNJ
Balance sheet
Cash$9.1M$17.2B
Total debt$24M$44.7B
Net debt / EBITDA0.41.1
Interest cover13.8×18.0×

Dividends and buybacks

INFUJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield3.5%0.9%
Shareholder yield3.5%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: INFU or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, InfuSystems or Johnson & Johnson?

By market value, Johnson & Johnson ($641B) is about 2,239.2 times InfuSystems ($286M), at today's prices.

How did INFU and JNJ stock do over the last 10 years?

Since November 21, 2016, INFU's price moved +626.7% and JNJ's +131.4%. With dividends: INFU +626.7% (+21.9% a year), JNJ +201.6% (+11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, INFU or JNJ?

The dividend yield at today's price is none for InfuSystems and 1.98% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of INFU and JNJ?

At today's price, the P/E is 30.3 for INFU and 39.9 for JNJ. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, InfuSystems or Johnson & Johnson?

Over the last twelve months, the net margin was 6.5% for InfuSystems and 16.2% for Johnson & Johnson, and the operating margin 9.8% and –. Revenue was $144M and $99.3B.

Which is the better investment, InfuSystems or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.